Ukraine is experiencing a significant increase in demand for clinical trials, positioning itself once again as a key market for pharmaceutical research. This resurgence, however, introduces substantial logistical complexities for companies involved in supplying study materials and patient medications.
The primary challenges stem from the need for long-distance road transportation within the country, navigating specific Ukrainian regulatory frameworks, and maintaining rigorous temperature control for sensitive pharmaceutical products throughout the journey. The COO of COREX, Mark Woolf, noted a clear uptick in interest over the past year, indicating a growing trend.
For freight forwarders and operations managers, this means a heightened focus on specialized pharma logistics. It requires expertise in cold chain management, including active and passive temperature-controlled solutions, and a deep understanding of customs procedures and local distribution networks in a potentially volatile region. The reliance on road transport implies careful route planning, risk assessment, and potentially longer transit times, which could impact lead times and require larger safety stocks. Forwarders must also be prepared for evolving regulations and infrastructure limitations.
While the article does not explicitly state future developments, the continued interest in Ukraine for clinical trials suggests an ongoing need for resilient and specialized pharmaceutical logistics services.
